Skip to main content

Table 1 Mean plus or minus the SD of etanercept serum concentration (μg/mL) at the time of maximum concentration (in parentheses) and 36 h after administration

From: Lymphatic delivery of etanercept via nanotopography improves response to collagen-induced arthritis

Route of administration Mean ± SD maximum serum concentration of etanercept, μg/mL (time of maximum concentration) Mean ± SD serum concentration of etanercept, μg/mL after 36 h administration
SOFUSA™ (n = 6) 18.28 ± 6.95 (2 h) 4.91 ± 3.76
IV (n = 6) 110.84 ± 15.03 (2 h) 47.06 ± 4.81
119.62 ± 16.73 (8 h)
ID (n = 6) 31.08 ± 5.68 (25 h) 20.65 ± 2.94
SC (n = 4) 13.50 ± 3.21 (24 h) 13.50 ± 3.21
  1. IV intravenous, ID intradermal, SC subcutaneous